{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:44:59Z","timestamp":1789764299091,"version":"4.0.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>SCAs are autosomal dominant neurodegenerative disorders caused by a gain-of-function protein with toxic activities, containing an expanded polyQ tract in the coding region. There are no treatments available to delay the onset, stop or slow down the progression of these pathologies. In this work we focus our attention on SCA1 which is one of the most common genotypes circulating in Italy. Here, we develop a CRISPR\/Cas9-based approach to reduce both forms of the ATXN1 protein, normal and mutated with expanded polyQ. We started with the screening of 10 different sgRNAs able to target Exon 8 of the <jats:italic>ATXN1<\/jats:italic> gene. The two most promising sgRNAs were validated in fibroblasts isolated from SCA1 patients, following the identification of the best transfection method for this type of cell. Our silencing approach significantly downregulated the expression of ataxin1, due to large deletions and the introduction of small changes in the <jats:italic>ATXN1<\/jats:italic> gene, evidenced by NGS analysis, without major effects on cell viability. Furthermore, very few significant guide RNA-dependent off-target effects were observed. These preliminary results not only allowed us to identify the best transfection method for SCA1 fibroblasts, but strongly support CRISPR\/Cas9 as a promising approach for the treatment of expanded polyQ diseases. Further investigations will be needed to verify the efficacy of our silencing system in SCA1 neurons and animal models.<\/jats:p>","DOI":"10.1038\/s41598-022-24299-y","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T12:04:22Z","timestamp":1669377862000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Suppressing gain-of-function proteins via CRISPR\/Cas9 system in SCA1 cells"],"prefix":"10.1038","volume":"12","author":[{"given":"Mariangela","family":"Pappad\u00e0","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ottavia","family":"Bonuccelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Buratto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariaconcetta","family":"Sicurella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Caproni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Fuselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Benazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Bertorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"De Sanctis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Cavallerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Simioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Tugnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Salvatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Marconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,24]]},"reference":[{"issue":"2","key":"24299_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00415-018-9076-4","volume":"266","author":"R Sullivan","year":"2019","unstructured":"Sullivan, R., Yau, W. Y., O\u2019Connor, E. & Houlden, H. Spinocerebellar ataxia: An update. J. Neurol. 266(2), 533\u2013544 (2019).","journal-title":"J. Neurol."},{"key":"24299_CR2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/acn3.156","volume":"2","author":"ML Monin","year":"2015","unstructured":"Monin, M. L. et al. Survival and severity in dominant cerebellar ataxias. Ann. Clin. Transl. Neurol. 2, 202\u2013207 (2015).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"24299_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-pathmechdis-012418-012857","volume":"14","author":"AP Lieberman","year":"2019","unstructured":"Lieberman, A. P., Shakkottai, V. G. & Albin, R. L. Polyglutamine repeats in neurodegenerative diseases. Annu. Rev. Pathol. 14, 1\u201327 (2019).","journal-title":"Annu. Rev. Pathol."},{"key":"24299_CR4","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3727\/096368914X678454","volume":"23","author":"HC Fan","year":"2014","unstructured":"Fan, H. C. et al. Polyglutamine (PolyQ) diseases: Genetics to treatments. Cell Transpl. 23, 441\u2013548 (2014).","journal-title":"Cell Transpl."},{"key":"24299_CR5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1146\/annurev.neuro.23.1.217","volume":"23","author":"HY Zoghbi","year":"2000","unstructured":"Zoghbi, H. Y. & Orr, H. T. Glutamine repeats and neurodegeneration. Annu. Rev. Neurosci. 23, 217\u2013247 (2000).","journal-title":"Annu. Rev. Neurosci."},{"key":"24299_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1083\/jcb.201105092","volume":"197","author":"HT Orr","year":"2012","unstructured":"Orr, H. T. Cell biology of spinocerebellar ataxia. J. Cell. Biol. 197, 167\u2013177 (2012).","journal-title":"J. Cell. Biol."},{"issue":"5","key":"24299_CR7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S1474-4422(04)00737-9","volume":"3","author":"L Sch\u00f6ls","year":"2004","unstructured":"Sch\u00f6ls, L., Bauer, P., Schmidt, T., Schulte, T. & Riess, O. Autosomal dominant cerebellar ataxias: Clinical features, genetics, and pathogenesis. Lancet Neurol. 3(5), 291\u2013304 (2004).","journal-title":"Lancet Neurol."},{"issue":"6","key":"24299_CR8","first-page":"959","volume":"54","author":"C Jodice","year":"1994","unstructured":"Jodice, C. et al. Effect of trinucleotide repeat length and parental sex on phenotypic variation in spinocerebellar ataxia I. Am. J. Hum. Gen. 54(6), 959\u2013965 (1994).","journal-title":"Am. J. Hum. Gen."},{"key":"24299_CR9","doi-asserted-by":"publisher","first-page":"29594","DOI":"10.1074\/jbc.M111.261032","volume":"286","author":"Y Nagashima","year":"2011","unstructured":"Nagashima, Y., Kowa, H., Tsuji, S. & Iwata, A. FAT10 protein binds to polyglutamine proteins and modulates their solubility. J. Biol. Chem. 286, 29594\u201329600 (2011).","journal-title":"J. Biol. Chem."},{"key":"24299_CR10","doi-asserted-by":"publisher","first-page":"e182","DOI":"10.1371\/journal.pmed.0040182","volume":"4","author":"K Watase","year":"2007","unstructured":"Watase, K. et al. Lithium therapy improves neurological function and hippocampal dendritic arborization in a spinocerebellar ataxia type 1 mouse model. PLoS Med. 4, e182. https:\/\/doi.org\/10.1371\/journal.pmed.0040182 (2007).","journal-title":"PLoS Med."},{"key":"24299_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/brain\/awp292","volume":"133","author":"FM Menzies","year":"2010","unstructured":"Menzies, F. M. et al. Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3. Brain 133, 93\u2013104 (2010).","journal-title":"Brain"},{"key":"24299_CR12","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s11064-015-1530-4","volume":"40","author":"ZZ Chen","year":"2015","unstructured":"Chen, Z. Z. et al. Trehalose attenuates the gait ataxia and gliosis of spinocerebellar ataxia type 17 mice. Neurochem. Res. 40, 800\u2013810 (2015).","journal-title":"Neurochem. Res."},{"key":"24299_CR13","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1093\/brain\/awr047","volume":"134","author":"I Nascimento-Ferreira","year":"2011","unstructured":"Nascimento-Ferreira, I. et al. Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado-Joseph disease. Brain 134, 1400\u20131415 (2011).","journal-title":"Brain"},{"key":"24299_CR14","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1172\/JCI43565","volume":"120","author":"D Grimm","year":"2010","unstructured":"Grimm, D. et al. Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liver. J. Clin. Investig. 120, 3106\u20133119 (2010).","journal-title":"J. Clin. Investig."},{"issue":"21","key":"24299_CR15","doi-asserted-by":"publisher","first-page":"e123193","DOI":"10.1172\/jci.insight.123193","volume":"3","author":"J Friedrich","year":"2018","unstructured":"Friedrich, J. et al. Antisense oligonucleotide-mediated ataxin-1 reduction prolongs survival in SCA1 mice and reveals disease-associated transcriptome profiles. JCI Insight. 3(21), e123193. https:\/\/doi.org\/10.1172\/jci.insight.123193 (2018).","journal-title":"JCI Insight."},{"key":"24299_CR16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/ana.25264","volume":"84","author":"HS McLoughlin","year":"2018","unstructured":"McLoughlin, H. S. et al. Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice. Ann. Neurol. 84, 64\u201377 (2018).","journal-title":"Ann. Neurol."},{"key":"24299_CR17","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.omtn.2019.07.004","volume":"17","author":"E KourKouta","year":"2019","unstructured":"KourKouta, E. et al. Suppression of mutant protein expression in SCA3 and SCA1 mice using a CAG repeat-targeting antisense oligonucleotide. Mol. Ther. Nucleic Acids. 17, 601\u2013614 (2019).","journal-title":"Mol. Ther. Nucleic Acids."},{"issue":"7","key":"24299_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.14304\/SURYA.JPR.V4N7.5","volume":"4","author":"J Chery","year":"2016","unstructured":"Chery, J. RNA therapeutics: RNAi and antisense mechanisms and clinical applications. Postdoc J. 4(7), 35\u201350 (2016).","journal-title":"Postdoc J."},{"key":"24299_CR19","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816\u2013821 (2012).","journal-title":"Science"},{"key":"24299_CR20","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1126\/science.1138140","volume":"315","author":"R Barrangou","year":"2007","unstructured":"Barrangou, R. et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315, 1709\u20131712 (2007).","journal-title":"Science"},{"key":"24299_CR21","doi-asserted-by":"publisher","first-page":"e00471","DOI":"10.7554\/eLife.00471","volume":"2","author":"M Jinek","year":"2013","unstructured":"Jinek, M. et al. RNA-programmed genome editing in human cells. Elife 2, e00471. https:\/\/doi.org\/10.7554\/eLife.00471 (2013).","journal-title":"Elife"},{"issue":"11","key":"24299_CR22","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1089\/scd.2017.0209","volume":"27","author":"S Ouyang","year":"2018","unstructured":"Ouyang, S. et al. CRISPR\/Cas9 targeted deletion of polyglutamine in spinocerebellar ataxia type 3 derived iPSCs. Stem Cells Dev. 27(11), 756\u2013770 (2018).","journal-title":"Stem Cells Dev."},{"key":"24299_CR23","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41398-021-01605-2","volume":"11","author":"L He","year":"2021","unstructured":"He, L. et al. CRISPR\/Cas9 mediated gene correction ameliorates abnormal phenotypes in spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cells. Transl. Psychiatry. 11, 479 (2021).","journal-title":"Transl. Psychiatry."},{"issue":"6","key":"24299_CR24","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/mt.2015.41","volume":"23","author":"Y Li","year":"2015","unstructured":"Li, Y. et al. Excision of expanded GAA repeats alleviates the molecular phenotype of Friedreich\u2019s ataxia. Mol. Ther. 23(6), 1055\u20131065 (2015).","journal-title":"Mol. Ther."},{"key":"24299_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3389\/fnins.2018.00075","volume":"12","author":"M Dabrowska","year":"2018","unstructured":"Dabrowska, M., Juzwa, W., Krzyzosiak, W. J. & Olejniczak, M. Precise excision of the CAG tract from the Huntingtin gene by Cas9 nickases. Front. Neurosci. 12, 75 (2018).","journal-title":"Front. Neurosci."},{"key":"24299_CR26","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1080\/21645698.2015.1137690","volume":"6","author":"VA Brazelton Jr","year":"2015","unstructured":"Brazelton, V. A. Jr. et al. A quick guide to CRISPR sgRNA design tools. GM Crops Food. 6, 266\u2013276 (2015).","journal-title":"GM Crops Food."},{"key":"24299_CR27","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.nbd.2018.05.002","volume":"116","author":"JM Perez Ortiz","year":"2018","unstructured":"Perez Ortiz, J. M. et al. Reduction of protein kinase A-mediated phosphorylation of ATXN1-S776 in Purkinje cells delays onset of Ataxia in a SCA1 mouse model. Neurobiol. Dis. 116, 93\u2013105 (2018).","journal-title":"Neurobiol. Dis."},{"issue":"21","key":"24299_CR28","doi-asserted-by":"publisher","first-page":"7846","DOI":"10.1128\/AEM.05220-11","volume":"77","author":"D Berry","year":"2011","unstructured":"Berry, D., Ben, M. K., Wagner, M. & Loy, A. Barcoded primers used in multiplex amplicon pyrosequencing bias amplification. Appl. Environ. Microbiol. 77(21), 7846\u20137849 (2011).","journal-title":"Appl. Environ. Microbiol."},{"key":"24299_CR29","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3389\/fmicb.2015.00731","volume":"6","author":"CW Herbold","year":"2015","unstructured":"Herbold, C. W. et al. A flexible and economical barcoding approach for highly multiplexed amplicon sequencing of diverse target genes. Front. Microbiol. 6, 731 (2015).","journal-title":"Front. Microbiol."},{"key":"24299_CR30","unstructured":"16S Metagenomic Sequencing Library Preparation Preparing 16S Ribosomal RNA Gene Amplicons for the Illumina MiSeq System. Preparing 16S Ribosomal RNA Gene Amplicons for the Illumina MiSeq System; https:\/\/support.illumina.com\/documents\/documentation\/chemistry_documentation\/16s\/16s-metagenomic-library-prep-guide-15044223-b.pdf."},{"issue":"W1","key":"24299_CR31","doi-asserted-by":"publisher","first-page":"W395","DOI":"10.1093\/nar\/gkaa434","volume":"48","author":"V Jalili","year":"2020","unstructured":"Jalili, V. et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2020 update. Nucleic Acids Res. 48(W1), W395\u2013W402 (2020).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"24299_CR32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29(1), 24\u201326 (2011).","journal-title":"Nat. Biotechnol."},{"key":"24299_CR33","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/mt.2016.10","volume":"24","author":"ML Maeder","year":"2016","unstructured":"Maeder, M. L. & Gersbach, C. A. Genome-editing technologies for gene and cell therapy. Mol. Ther. 24, 430\u2013446 (2016).","journal-title":"Mol. Ther."},{"issue":"1","key":"24299_CR34","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1080\/10717544.2018.1474964","volume":"25","author":"CA Lino","year":"2018","unstructured":"Lino, C. A., Harper, J. C., Carney, J. P. & Timlin, J. A. Delivering CRISPR: A review of the challenges and approaches. Drug Deliv. 25(1), 1234\u20131257 (2018).","journal-title":"Drug Deliv."},{"key":"24299_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ymeth.2017.04.003","volume":"121\u2013122","author":"MA DeWitt","year":"2017","unstructured":"DeWitt, M. A., Corn, J. E. & Carroll, D. Genome editing via delivery of Cas9 ribonucleoprotein. Methods 121\u2013122, 9\u201315 (2017).","journal-title":"Methods"},{"key":"24299_CR36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ymeth.2017.03.021","volume":"121\u2013122","author":"AM Jacobi","year":"2017","unstructured":"Jacobi, A. M. et al. Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotes. Methods 121\u2013122, 16\u201328 (2017).","journal-title":"Methods"},{"issue":"4","key":"24299_CR37","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1089\/ten.tec.2017.0435","volume":"24","author":"NY Becerra","year":"2018","unstructured":"Becerra, N. Y. et al. Polyplex system versus nucleofection for human skin cell transfection and effect of internal ribosome entry site sequence. Tissue Eng. Part C Methods. 24(4), 233\u2013241 (2018).","journal-title":"Tissue Eng. Part C Methods."},{"issue":"4","key":"24299_CR38","first-page":"e3152","volume":"37","author":"M Kucharski","year":"2021","unstructured":"Kucharski, M., Mrowiec, P. & Oc\u0142on, E. Current standards and pitfalls associated with the transfection of primary fibroblast cells. Biotechnol. Prog. 37(4), e3152 (2021).","journal-title":"Biotechnol. Prog."},{"issue":"14","key":"24299_CR39","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows\u2013Wheeler transform. Bioinformatics 25(14), 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"24299_CR40","unstructured":"Garrison, E. & Marth, G. Haplotype-based variant detection from short-read sequencing. arViv. 1207.3907 [q-bio.GN] (2012)."},{"issue":"1","key":"24299_CR41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41596-020-00431-y","volume":"16","author":"XR Bao","year":"2021","unstructured":"Bao, X. R. et al. Tools for experimental and computational analyses of off-target editing by programmable nucleases. Nat. Protoc. 16(1), 10\u201326 (2021).","journal-title":"Nat. Protoc."},{"key":"24299_CR42","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1001\/archneur.61.5.727","volume":"61","author":"A Brusco","year":"2004","unstructured":"Brusco, A. et al. Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of spinocerebellar ataxia genes and CAG\/CTG repeat expansion detection in 225 Italian families. Arch. Neurol. 61, 727\u2013733 (2004).","journal-title":"Arch. Neurol."},{"key":"24299_CR43","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1172\/JCI92087","volume":"127","author":"S Yang","year":"2017","unstructured":"Yang, S. et al. CRISPR\/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington\u2019s disease. J. Clin. Investig. 127, 2719\u20132724 (2017).","journal-title":"J. Clin. Investig."},{"issue":"6","key":"24299_CR44","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s10529-016-2064-9","volume":"38","author":"X Yu","year":"2016","unstructured":"Yu, X. et al. Improved delivery of Cas9 protein\/gRNA complexes using lipofectamine CRISPRMAX. Biotechnol. Lett. 38(6), 919\u2013929 (2016).","journal-title":"Biotechnol. Lett."},{"key":"24299_CR45","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jconrel.2021.02.026","volume":"332","author":"S Abbasi","year":"2021","unstructured":"Abbasi, S. et al. Co-encapsulation of Cas9 mRNA and guide RNA in polyplex micelles enables genome editing in mouse brain. J. Control Release. 332, 260\u2013268 (2021).","journal-title":"J. Control Release."},{"key":"24299_CR46","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3389\/fnagi.2019.00373","volume":"11","author":"WM Pardridge","year":"2020","unstructured":"Pardridge, W. M. Blood-brain barrier and delivery of protein and gene therapeutics to brain. Front. Aging Neurosci. 11, 373 (2020).","journal-title":"Front. Aging Neurosci."},{"issue":"2","key":"24299_CR47","doi-asserted-by":"publisher","first-page":"614","DOI":"10.7150\/thno.47007","volume":"11","author":"S Zhang","year":"2021","unstructured":"Zhang, S., Shen, J., Li, D. & Cheng, Y. Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR\/Cas9 genome editing. Theranostics. 11(2), 614\u2013648 (2021).","journal-title":"Theranostics."},{"issue":"6","key":"24299_CR48","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.neuron.2018.02.013","volume":"97","author":"MW Rousseaux","year":"2018","unstructured":"Rousseaux, M. W. et al. ATXN1-CIC complex is the primary driver of cerebellar pathology in spinocerebellar ataxia type 1 through a gain-of-function mechanism. Neuron 97(6), 1235\u20131243 (2018).","journal-title":"Neuron"},{"issue":"5","key":"24299_CR49","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.cell.2019.07.043","volume":"178","author":"J Suh","year":"2019","unstructured":"Suh, J. et al. Loss of ataxin-1 potentiates Alzheimer\u2019s pathogenesis by elevating cerebral BACE1 transcription. Cell 178(5), 1159\u20131175 (2019).","journal-title":"Cell"},{"key":"24299_CR50","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.neuroscience.2016.02.011","volume":"322","author":"M Asher","year":"2016","unstructured":"Asher, M., Johnson, A., Zecevic, B., Pease, D. & Cvetanovic, M. Ataxin-1 regulates proliferation of hippocampal neural precursors. Neuroscience 322, 54\u201365 (2016).","journal-title":"Neuroscience"},{"key":"24299_CR51","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.omtn.2020.07.030","volume":"21","author":"B O\u2019Callaghan","year":"2020","unstructured":"O\u2019Callaghan, B. et al. Antisense oligonucleotide therapeutic approach for suppression of ataxin-1 expression: A safety assessment. Mol. Ther. Nucleic Acids. 21, 1006\u20131016 (2020).","journal-title":"Mol. Ther. Nucleic Acids."},{"key":"24299_CR52","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.plaphy.2018.03.027","volume":"131","author":"US Kadam","year":"2018","unstructured":"Kadam, U. S., Shelake, R. M., Chavhan, R. L. & Suprasanna, P. Concerns regarding \u201coff-target\u201d activity of genome editing endonucleases. Plant Physiol. Biochem. 131, 22\u201330 (2018).","journal-title":"Plant Physiol. Biochem."},{"key":"24299_CR53","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nbt.2623","volume":"31","author":"Y Fu","year":"2013","unstructured":"Fu, Y. et al. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat. Biotechnol. 31, 822\u2013826 (2013).","journal-title":"Nat. Biotechnol."},{"key":"24299_CR54","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nbt.2647","volume":"31","author":"PD Hsu","year":"2013","unstructured":"Hsu, P. D. et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 31, 827\u2013832 (2013).","journal-title":"Nat. Biotechnol."},{"key":"24299_CR55","doi-asserted-by":"publisher","first-page":"7473","DOI":"10.1093\/nar\/gku402","volume":"42","author":"Y Lin","year":"2014","unstructured":"Lin, Y. et al. CRISPR\/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences. Nucleic Acids Res. 42, 7473\u20137485 (2014).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24299-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24299-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24299-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T14:15:22Z","timestamp":1669385722000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24299-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,24]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["24299"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-24299-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,24]]},"assertion":[{"value":"1 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.\u00a0The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20285"}}